ArticleThe Lancet regional health. Europe2026

GLP-1 receptor agonists in type 1 diabetes: expanding the therapeutic landscape beyond insulin.

George D Dimitriadis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.